Tirzepatide 10mg

Tirzepatide is a dual incretin receptor agonist with activity at both GIP and GLP-1 receptors. Its pharmacology has been extensively studied in metabolic research, including glucose regulation, appetite-related signalling and body-weight endpoints. The compound's dual-receptor mechanism distinguishes it from GLP-1-only agonists.Research-use reference: Tirzepatide is a regulated therapeutic substance in many settings. This description is informational only and must not be treated as authorisation to advertise or supply it outside applicable Australian requirements.